Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
HPAPI
Sort By
Newest First
1 / 2
1 / 2
HPAPIs
An Introduction to HPAPIs and Cytotoxic Drugs
Roots Analysis
PAO-04-23-CL-04
April 25, 2023
High Containment
Olon, Leading International API Supplier, Announces A New Investment That Will Further Expand its Global High Containment Platform a New High Containment Line in the Site Located in India
Olon
PR-M09-22-06
September 27, 2022
Complex Chemistry
Solving Complex Chemical Problems Across All Phases of NCE Programs
Luigi Trussardo
Olon Ricerca Bioscience
PAO-10-21-CL-11
October 21, 2021
Process Development
Designing More Sustainable Small Molecule API Manufacturing Processes
Marko Salo; Arne Grumann
Fermion
PAO-09-21-CL-05
September 16, 2021
High Potency
Streamlining Highly Potent Drug Commercialization
Norbert Straub; Uwe Korn; Robert Klehr
Fareva
PAO-04-21-CL-04
April 19, 2021
HPAPI
A Successful Approach for Managing Unexpected Increases in Potency for HPAPIs
Daniela Kovats
Fareva
PAO-01-21-CL-01
January 11, 2021
Small Molecule
The Importance of a Global Leader in Small Molecule Manufacturing During the COVID-19 Pandemic
Pierre Luzeau, Ph.D.
Seqens
PAP-Q4-20-CL-025
December 09, 2020
Specialized OSD Services
Avara Pharmaceutical Services: Specialization with a Client-Centric Approach
Deborah A. Graham
Avara Pharmaceutical Services
PAP-Q4-20-CL-003
December 09, 2020
SEQENS Inaugurates HPAPI Unit
Seqens
PR-M08-20-NI-47
August 28, 2020
Expansion
Catalent Adds Potent Manufacturing Capabilities at its Buenos Aires, Argentina Site
Catalent
PR-M08-20-NI-13
August 07, 2020
HPAPIs
Essentials of an Industry-Leading CDMO Partner for Highly Potent Projects
Brian P. Haney, Ph.D.
Curia (formerly AMRI)
PAP-Q2-20-CL-031
July 01, 2020
Investment in Innovation
Should You Choose a Commercial HPAPI Manufacturer for Your Clinical Program?
David Bastie; George Hlass
Fareva
PAO-11-2019-CL-001
December 06, 2019
Global Network
Applying an Established and Continuously Upgraded Global Network for CDMO Services
Lorraine Hill
Aspen Pharma
PAP-Q3-19-CL-002-2034
October 28, 2019
HPAPI
Successful US FDA Inspection of Asymchem Tianjin 1 HPAPI Development and Manufacturing Facility
Asymchem
PR-M03-19-NI-077
March 27, 2019
HPAPI
Investing in the Future of Potent Compounds
Frederic Desdouits
Seqens
PAP-Q1-2019-CL-028
March 12, 2019
Lyophilization
Flow Sciences, Inc. Partners with Three Companies to Contain Lyophilization Process of New HPAPI
Flow Sciences, Inc.
PR-M01-19-NI-052
January 15, 2019
Oral Solid Dose
HPAPIs and Two-Piece Liquid-Fill Capsules: The Perfect Match
Tom Breshamer
CapsCanada
PAO-06-18-CL-001
June 14, 2018
The Introduction of Robotics: Creating a Truly Sterile Environment
Nice Insight
PTV-M03-17-IN-001
May 02, 2017
Joint Venture Contract Services – A CDMO’s Approach to Being a True Partner
BIOVECTRA
PAP-Q03-16-CL-016
August 01, 2016
Creating a Global C‘R’DMO for the Future of (Bio)pharma: Effective Strategies and Tactics
Steven R. Hagen, Ph.D.; Dawn Von Rohr
Curia (formerly AMRI)
PAP-Q03-16-CL-001
August 01, 2016
